polio prevention

polio prevention


8 New Polio Cases Confirmed During 2019 - PrecisionVaccinations

Posted: 30 Mar 2019 06:09 AM PDT

The Global Polio Eradication Initiative (GPEI) weekly report noted 8 new polio cases have been confirmed during 2019. 

The March 27th GPEI report confirmed polio cases in Pakistan (2) involving wild poliovirus type 1 (WPV1), and in Nigeria (2) involving circulating vaccine-derived poliovirus type 2 (cVDPV2). 

Dr. Tedros Adhanom Ghebreyesus, the World Health Organization (WHO) Director-General and Chair of the Polio Oversight Board, said in a press release that he 'urged everyone involved in the GPEI to ensure polio will finally be assigned to the history books by 2023.' 

Polio is caused by the poliovirus, which spreads from person to person, by drinking water or eating food that is contaminated with infected feces. 

In certain cases, polio can invade an infected person's brain and spinal cord, causing paralysis, says the Centers for Disease Control and Prevention (CDC). 

The weekly GPEI report includes the following country-based updates:

  • Afganistan:
    • No wild poliovirus type 1 (WPV1) cases were reported in the past week. There are two WPV1 cases reported in 2019. The total number of WPV1 cases for 2018 remains 21.
    • No WPV1-positive environmental samples were reported in the past week.
    • The Technical Advisory Group (TAG) for polio eradication met on 15-16 January 2019 to assess the progress made towards polio eradication in Afghanistan in 2018 and made recommendations for the way forward in 2019.
    • Read the latest polio update from Afghanistan to see information on cases, surveillance and vaccination campaigns.
  • Central Africa:
    • No cases of circulating vaccine-derived poliovirus type 2 (cVDPV2) were reported this week in the Democratic Republic of the Congo (DRC). The total number of cVDPV2 cases reported in 2018 is 20.
    • The most recent cVDPV2 AFP case was reported from Mufunga-Sampwe district in Haut-Katanga province with the onset of paralysis on 7 October 2018.
    • DRC is affected by four separate cVDPV2 outbreaks, in the provinces of Haut Katanga; Mongala, Maniema and Haut Lomami/Tanganyika/Haut Katanga/Ituri.
    • Read the latest on the  Democratic Republic of the Congo to see information on surveillance and vaccination campaigns.
    • Learn more about vaccine-derived polioviruses through this short animation or this 'Coffee with Polio Experts'
  • Horn of Africa:
    • No circulating vaccine-derived poliovirus type 2 (cVDPV2) cases were reported in the past week.
    • The Horn of Africa is currently affected by separate outbreaks of circulating vaccine-derived poliovirus type 2 (cVDPV2) and type 3 (cVDPV3), reporting both AFP cases and environmental positive samples.
    • Somalia has reported a total of 12 cVDPV cases (five type 2, six type 3 and one, coinfection of both type 2 and type 3) in 2018.
    • The most recent cVDPV2 virus was isolated from an environmental sample collected on 11 October 2018 from Waberi district in Banadir province.  
    • The most recent cVDPV3 virus was isolated from an environmental sample also from Waberi district, Banadir province collected on 23 August 2018.
    • Circulating VDPV2 has also been detected during 2018 in one environmental sample in Kenya collected on 21 March 2018.
    • Outbreak response to both virus types is currently being implemented in line with internationally-agreed guidelines. Large-scale supplementary immunization activities (SIAs) have been implemented in Banadir, Lower Shabelle and Middle Shabelle regions, Somalia.
    • WHO and partners continue to support local public health authorities across the Horn of Africa in conducting field investigations and risk assessments.
    • Read the latest polio update for Somalia and Kenya to see information on surveillance and vaccination campaigns.
  • Indonesia:
    • No circulating vaccine-derived poliovirus type 1 (cVDPV1) cases were reported this week.
    • In total, three genetically-linked circulating vaccine-derived poliovirus type 1 (cVDPV1) isolates were detected from Papua province.  In addition to the above-listed isolate, cVDPV1 was isolated from an acute flaccid paralysis (AFP) case, with the onset of paralysis on 27 November 2018, and from a sample of a healthy community contact, collected on 24 January 2019.  This outbreak is not linked to the cVDPV1 currently affecting neighboring Papua New Guinea.
    • The GPEI and partners are working with country counterparts to support the local public health authorities in conducting a field investigation (clinical, epidemiological and immunological) and thorough risk assessment to discuss planning and implementation of immunization and outbreak response.
  • Lake Chad Basin:
    • No case of circulating vaccine-derived poliovirus type 2 (cVDPV2) has been reported in the past week. The most recent cVDPV2 isolated in the country was in Magaria district, Zinder province with the onset of paralysis on 5 December 2018.
    • The total number of cVDPV2 cases in 2018 reported in Niger in 2018 is ten.  The outbreak is genetically-linked to the cVDPV2 outbreak originating in Jigawa, Nigeria. The virus was isolated from children with acute flaccid paralysis (AFP) from Zinder region, located in the south of Niger and on the border with Nigeria, with dates of onset of paralysis ranging from 18 July through 5 December 2018.
    • Acute flaccid paralysis surveillance and routine immunization across the country with a focus on the infected provinces and the provinces at the international borders with Nigeria are being reinforced.
    • Active case finding for additional AFP cases is continuing, and additional surveillance measures such as increasing the frequency and extent of environmental surveillance and community sampling of healthy individuals being expanded.
  • Mozambique:
    • No case of circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreak has been reported this week.  The total number of cases in 2018 remains 1.
    • One circulating vaccine-derived poliovirus type 2 (cVDPV2) isolate was detected, from an acute flaccid paralysis (AFP) case (with onset of paralysis on 21 October 2018, in a six-year-old girl with no history of vaccination, from Molumbo district, Zambézia province), and two isolated from a community contact of the case reported on 10 and 17 December 2018.
    • The GPEI and partners are working with country counterparts to support the local public health authorities in conducting a field investigation (clinical, epidemiological and immunological) and thorough risk assessment to discuss planning and implementation of immunization and outbreak response.
    • In January 2017, a single VDPV2 virus had been isolated from a 5-year old boy with AFP, also from Zambézia province (Mopeia district).  Outbreak response was conducted in the first half of 2017 with monovalent oral polio vaccine type 2 (mOPV2).
    • Read the latest polio update for Mozambique to see information on cases, surveillance and response to the developing outbreak.
  • Nigeria:
    • Two cases of circulating vaccine-derived poliovirus type 2 have been reported this week in Konduga LGA, Borno State and Baruten LGA, Kwara State with the onset of paralysis reported on 14 February and 20 February 2019 respectively. There are now four cVDPV2 cases reported in 2019 so far. The total number of cVDPV2 cases in 2018 remains 34.
    • One cVDPV2-positive environmental sample has been reported this week in Maiduguri, Borno State. The sample was collected on 26 February 2019.
    • No cases of wild poliovirus type 1 (WPV1) has been reported in the country since the one detected from Borno State with a date of onset of paralysis on 21 August 2016.
    • The country continues to be affected by two separate cVDPV2 outbreaks, the first centered in Jigawa State with subsequent spread to other states as well as to the neighboring Republic of Niger, and the second in Sokoto State.
    • Recent confirmation of spread of one of the cVDPV2 outbreaks, both within Nigeria and internationally, underscores the urgent need to fill remaining vaccination gaps in the ongoing outbreak response and to optimize the geographic extent and operational quality of mOPV2 response.
    • At the same time, outbreak response to WPV1 continues, including efforts to address surveillance and immunity gaps in parts of Borno State.
    • Read the latest polio update for Nigeria to see information on surveillance and vaccination campaigns.
  • Pakistan:
    • Two cases of wild poliovirus type 1 (WPV1) were reported this week: one in Khyber District, Khyber Pakhtunkhwa Tribal District (KPTD) and one in Layari in Karachi, Sindh province. The onsets of paralysis were on 14 February 2019 and 25 February 2019 respectively. There are now a total of six WPV1 cases reported in 2019.  The total number of WPV1 cases in 2018 remains 12.
    • 15 WPV1-positive environmental samples were reported in the past week: four from Lahore district, Punjab province; one each from Saddar, Liaqat, Baldia Town, Orangi Town and two from Gadap in Karachi, Sindh province; one from Hyderabad district, Sindh province; one from Killa Abdullah and one from Quetta in Balochistan province; one each from Kohat and Bannu in Khyber Pakhtunkhwa province.
    • The samples were collected from 27 February 2019 to 12 March 2019. So far in 2019, a total of 65 environmental positive samples have been reported. The full-year 2018 total remains 140.
    • Read the latest polio update from Pakistan to see information on cases, surveillance and vaccination campaigns.

To alert USA citizens, the CDC issued various Travel Alerts, which recommend that all travelers to these countries be fully vaccinated against polio.

Recommended:

The CDC says adults who completed their routine polio vaccine series as children should receive a single, lifetime adult booster dose of the polio vaccine.     

And, the CDC recommends that all infants and children in the USA be vaccinated against polio, as part of a routine, age-appropriate vaccination series.     

Besides the polio vaccination, the CDC suggests you are up-to-date on several Routine Vaccines before visiting these countries.

These vaccines and related medications can be found at most 'travel-pharmacies' in the USA.   

Pre-trip, vaccine and medication counseling appointments can be scheduled at Vax-Before-Travel.

Polio vaccine: Jonas Salk's game-changer for a panicked nation - WKYC.com

Posted: 26 Mar 2019 05:17 AM PDT

Polio caused panic nationwide midway through the 20th century, with outbreaks crippling or paralyzing an average of 35,000 people in the U.S. each year, according to the Centers for Disease Control and Prevention. Parents feared letting their children outside and quarantines were imposed in areas where polio outbreaks had occurred.

In 1953, Dr. Jonas Edward Salk announced to the world that he was testing a vaccine on his own family that would prove to be a game-changer.

The CDC says polio -- more specifically known as paralytic poliomyelitis -- "is a crippling and potentially deadly infectious disease. It is caused by the poliovirus. The virus spreads from person to person and can invade an infected person's brain and spinal cord, causing paralysis." Because of this, hospitals set up rooms where some children had to live in iron lung machines to survive.

Tiny Polio Victim 1952

Martha Ann Murray, who at two months is the youngest Arizonian ever placed in a iron lung, is watched by nurse Martha Sumner in St. Mary's Hospital in Tucson, Az., Sept. 23, 1952, where she is critically ill with polio. (AP Photo)

AP

Salk had an idea that went against popular scientific opinion, according to the Salk Institute. He believed using a "killed" poliovirus could safely immunize people without risk of infection. He was so confident in his vaccine that he tested it on himself and his own wife and children. On March 26, 1953, Salk went on national radio to announce the tests were underway.

Salk and his family all developed antibodies against polio with no adverse reactions.

Jonas Salk family polio

Dr. Jonas E. Salk reads LIFE magazine with his wife and three boys in their home in Ann Arbor, Mi. on April 11, 1955. (AP Photo)

AP

After nationwide testing began in 1954, Salk's vaccine was announced as a success on April 12, 1955. Widespread manufacturing began and, according to the Salk Institute, the average number of U.S. polio cases dropped to 910 by 1962. Today, it is virtually non-existent in most of the world, according to National Geographic.

Salk could have earned a fortune for his vaccine, but he sought the greater good and never patented it, according to the Salk Institute.

He also tried finding a vaccine for HIV, the virus that causes AIDS. Although he did not have the condition, he announced in 1991 he would do as he did with his polio vaccine -- he would test it on himself. Before he could complete his work, Salk died on June 23, 1995 at age 80.

Vaccine Opposition History Jonas Salk

FILE - In this Oct. 7, 1954 file photo, Dr. Jonas Salk, developer of the polio vaccine, holds a rack of test tubes in his lab in Pittsburgh, Pa. (AP Photo/File)

AP

Rotary Club of Buckhead honors ad man Fitzgerald - MDJOnline.com

Posted: 31 Mar 2019 07:53 AM PDT

When the Rotary Club of Buckhead decided who to honor at its Rotary Foundation Ball, it found someone who exemplifies its "service above self" motto.

At the event March 30 at Flourish in Buckhead, the club lauded Dave Fitzgerald, founder and chair of Fitzco, a west Midtown-based advertising and marketing agency formerly called Fitzgerald + Co., for his service to Atlanta and beyond.

"I'm honored to be honored by a group like Rotary that is all about service," said Fitzgerald, a member of the Rotary Club of Atlanta, which meets downtown. "Everyone in this room is doing stuff that is beyond what normal people do. They give all of their time, their treasure, their talent to make this world a better place.

"You get some issues that have been thrown on our doorstep, what I call front-porch issues that happen in Atlanta, but they've also managed to, by the way, cure polio globally. There were 14 (worldwide) cases of polio last year, and when they started the initiative in 1988, there were a thousand cases a day. Now it's 14 cases a year, limited to Afghanistan, Nigeria and Pakistan. This is the power of people working together to do great things."

Polio is a disease that causes paralysis and even death and has infected millions of individuals worldwide, mostly children, since it was discovered over 100 years ago. According to the Centers for Disease Control and Prevention's website, in 1988 there were 350,000 cases of polio in 125 countries worldwide. In the 1940s and 1950s, there was an average of 35,000 polio cases annually in the United States, peaking at 58,000 in 1952.

"We're all here to raise money for great front-porch issues, not (just) global issues," Fitzgerald said. "We've got to do what we can do. … It's kind of daunting to think of all the issues that we are confronting globally, but folks at Rotary do the day-to-day stuff that gets things done locally but also manages the ones globally like curing polio."

On a local level, the Buckhead club also supports the Atlanta Ronald McDonald House Charities, Open Hand and an initiative to end human trafficking.

Fitzgerald was honored for his involvement with several local and national organizations. He is board chair of St. Joseph's Health System, incoming board chair of Cristo Rey Jesuit High School and past board chair of the Buckhead Coalition, all Atlanta organizations. Fitzgerald also is a board member of the coalition, the Atlanta Speech School and the National Advertising Review Board.

He previously served as president of the Atlanta Ad Club and chair and board member of the American Association of Advertising Agencies' Atlanta Council. Fitzgerald is chair of the Atlanta St. Patrick's Parade and has been selected as one of the Top 100 Irish-American Business People by the Irish Times each year since 2004.

"I just think everything he's done for the community was the right fit for us," club President Brent Adams said of Fitzgerald being selected as this year's ball honoree. "We're all about giving back to the community. I think he exemplifies that for us."

Of Rotary's efforts to end polio worldwide, Adams said, "There's two people in the room tonight who had polio as children and you wouldn't know it. I think it speaks volumes for what's happened over the years but also what Rotary has done worldwide in helping to eradicate polio. I think there's only been three cases this year."

Club Treasurer Mark Johnson, who has known Fitzgerald for more than 35 years, said choosing him as the honoree was easy.

"What I'm going to say in my introduction is I hope I could be Dave Fitzgerald when I grow up," Johnson said. "He is one of the nicest, smartest people I know. He has done amazing things for the community. He built a fabulous advertising agency, and there's no telling what's next."

Comments

Popular posts from this blog

Roseola vs. measles rash: What is the difference? - Medical News Today

poliomyelitis treatment

Coronavirus fake news echoes century-old polio fears - Newsroom